Out of the haze and into the light, Canadians are finally waking from their 50-year psychedelic slumber. 

Once thought to be a lost generation of marmalade skies, the psychedelic counterculture of the 1960s has evolved into a modern medical renaissance. It is one that is transforming psychiatry in the way we treat mental illness and relieve palliative and end-of-life suffering. It also

Stephanie Lipp and Leonedest Gillis entered the Genesis Evolution accelerator in St. John's with plans to sell a mushroom-based nutraceutical product.

When they emerged from the program eight weeks later, they had pivoted to an entirely new business, and on Friday, their revised plan helped them win $55,000 of cash and in-kind services from the BioInnovation Challenge accelerator and startup

Development group Halifax Partnership has named Patrick Farrar its new Director of Innovation responsible for promoting innovative companies in the city.

“We are thrilled to have Patrick join our team to continue supporting the rapid growth of startups and scaleups in Halifax,” said Wendy Luther, HP President and CEO, in a statement.

“Patrick will work with partners to advance Halifax’s

St. John’s-based BreatheSuite, whose products help people to use their inhalers properly, has been accepted into the seventh cohort of the prestigious Lazaridis ScaleUp program.

The Lazaridis Institute for the Management of Technology Enterprises, part of the Lazaridis School of Business and Economics at Wilfrid Laurier University in Kitchener, Ont., last week named 11 Canadian companies to the

Granville Biomedical, the St. John’s-based maker of medical testing swabs, has formed a partnership with Toronto’s Inagene Diagnostics to develop a cheek swab for testing patients’ DNA and determining which medications are most compatible with their biology.

Co-Founder and CEO Christine Goudie said in an interview that the cheek swab uses a similar design to a COVID-19 nasal testing swab her

St. John’s-based Mysa Smart Thermostat has raised a $20.3 million Series B funding round to scale up its marketing and finance an international expansion.

The deal was led by Cycle Capital Management, a cleantech-focused venture capital fund based in Montreal. The other investors included Bruce Croxon’s Round13 Capital via its Earth Tech Fund, as well as Climate Innovation Capital, BDC Capital,

Innovacorp has put out a call for applicants to its GreenShoots funding and mentorship program, which will offer six agtech, biotech or cleantech companies up to $40,000 in grants.

The competition is run by Innovacorp, the Nova Scotia Innovation Hub and Guelph, Ont.-based Bioenterprise Corporation. To qualify, startups must have booked less than $1 million in cumulative sales and not have

The annual Spark Nova Scotia startup competition has awarded five-figure cash prizes to 10 startups, with a strong focus this year on medtech and cleantech innovation.

The 10 companies received a combined $375,000, with the top two bagging $50,000 each and the smallest prize being $10,000. Four of the 10 winners sell health-related products and three are involved in cleantech.

Now in its

Halifax’s Densitas has inked a deal with nonprofit RAD-AID International to deploy its intelliMammo AI mammography software at a hospital in Guyana, where the country’s government runs a publicly funded screening program aimed at combatting rising breast cancer rates.

The intelliMammo platform consolidates three previous software offerings from Densitas that measured patients’ breast density,

Swiftsure Innovations, the Pasadena, NL-based startup developing a device for cleaning the mouths and throats of people on ventilators, has raised $1.05 million in an oversubscribed seed round.

The round’s backers included Threshold Impact, Killick Capital, Pluto Investments, Pelorus Venture Capital and female-focused venture capital firm Sandpiper Ventures. Sandpiper revealed it had invested in